About Central Glory Group
An innovation-driven pharmaceutical enterprise delivering high-quality drug intermediates and APIs to partners worldwide.
Science as the foundation, quality first.
Central Glory Group Ltd (CGG), a modern pharmaceutical enterprise driven by innovation, is committed to delivering high-quality pharmaceutical products — including drug intermediates and APIs — to customers around the world. Specializing in the development of small-molecule drugs and other niche therapeutic areas, CGG has established an integrated industrial platform encompassing R&D, production, and sales through sustained technological investment.
The company adheres to the principle of "science as the foundation, quality first," maintaining a strict quality management system aligned with international standards to ensure every product is safe, effective, and reliable. CGG maintains a mature and stable product pipeline while also prioritizing forward-looking strategy, collaborating closely with leading domestic and international research institutions to advance new drug development and the translation of innovative technologies.
As a responsible participant in global healthcare, CGG pursues excellence while actively fulfilling its corporate social responsibilities — working to improve drug accessibility, provide professional support to healthcare professionals, and safeguard the health and wellbeing of patients worldwide. Looking ahead, CGG will continue to place innovation at the center of its growth, contributing further to global health initiatives.
A modern R&D platform built on partnership.
Through an extensive network of partner institutions, CGG has built a comprehensive, modern R&D platform designed to provide clients with an efficient service-response mechanism. The company has established collaborations with a number of large pharmaceutical companies and research organizations, supporting its integrated approach to small-molecule drug development.
An established network across two continents.
Let's discuss your API or intermediate sourcing needs.
Whether you're evaluating a new molecule or scaling to commercial supply, our team is ready to walk through the process with you.